Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Lansky

Showing results (321-330 of 471) with videos related to

Pageof 48
Sort By:
JACC. Cardiovascular Imaging|March 17, 2012
Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromesAlexandra J Lansky, Vivian G Ng, Akiko Maehara, et al.
Circulation|August 27, 2003
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialJames E Tcheng, David E Kandzari, Cindy L Grines, et al.
Journal of the American College of Cardiology|April 6, 2005
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound studyKenichi Fujii, Stéphane G Carlier, Gary S Mintz, et al.
The American Journal of Cardiology|September 3, 2004
Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)H Mehrdad Sadeghi, Cindy L Grines, Harish R Chandra, et al.
The American Journal of Cardiology|January 16, 2007
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitorsKishore J Harjai, Gregg W Stone, Cindy L Grines, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantationXuebo Liu, Kenichi Tsujita, Akiko Maehara, et al.
Journal of the American College of Cardiology|September 19, 2003
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trialDavid A Cox, Gregg W Stone, Cindy L Grines, et al.
Journal of the American College of Cardiology|June 4, 2011
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysisGeorge D Dangas, Roxana Mehran, Eugenia Nikolsky, et al.
European Heart Journal. Acute Cardiovascular Care|July 27, 2014
Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream"Mohamed Majidi, Andrzej S Kosinski, Sana M Al-Khatib, et al.
Journal of the American College of Cardiology|June 6, 2006
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trialsJeffrey W Moses, Gregg W Stone, Eugenia Nikolsky, et al.
Pageof 48

Showing results (321-330 of 471) with videos related to

Sort By:
Pageof 48
JACC. Cardiovascular Imaging|March 17, 2012
Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromesAlexandra J Lansky, Vivian G Ng, Akiko Maehara, et al.
Circulation|August 27, 2003
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialJames E Tcheng, David E Kandzari, Cindy L Grines, et al.
Journal of the American College of Cardiology|April 6, 2005
Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound studyKenichi Fujii, Stéphane G Carlier, Gary S Mintz, et al.
The American Journal of Cardiology|September 3, 2004
Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)H Mehrdad Sadeghi, Cindy L Grines, Harish R Chandra, et al.
The American Journal of Cardiology|January 16, 2007
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitorsKishore J Harjai, Gregg W Stone, Cindy L Grines, et al.
JACC. Cardiovascular Interventions|October 24, 2009
Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantationXuebo Liu, Kenichi Tsujita, Akiko Maehara, et al.
Journal of the American College of Cardiology|September 19, 2003
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trialDavid A Cox, Gregg W Stone, Cindy L Grines, et al.
Journal of the American College of Cardiology|June 4, 2011
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysisGeorge D Dangas, Roxana Mehran, Eugenia Nikolsky, et al.
European Heart Journal. Acute Cardiovascular Care|July 27, 2014
Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream"Mohamed Majidi, Andrzej S Kosinski, Sana M Al-Khatib, et al.
Journal of the American College of Cardiology|June 6, 2006
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trialsJeffrey W Moses, Gregg W Stone, Eugenia Nikolsky, et al.
Pageof 48